Combination therapy for chronic hepatitis C infection
AssigneeSchering Corporation
InventorsJanice K. Albrecht, Paul C. Grint
Life of this patent
Estimating the term…
Abstract
There is disclosed a method for treating chronic hepatitis C infection in patients in need of such treating comprising administering an amount of alpha interferon in association with an amount of ribavirin effective to treat chronic hepatitis C infection with the absence or substantial reduction of side effects associated with administration of ribavirin and alpha interferon.
Claims13
A method for treating Hepatitis C infection in a patient comprising administering to said patient an amount of alpha interferon and an amount of ribavirin wherein the amount of alpha interferon administered is less than 3 million IU weekly, QOD or daily and said alpha interferon consists of interferon alpha2.
Dependencies are inferred from the claim text.